glp-1 and osteoporosis Drugs Could Raise the Risk of Weaker Bones Gout glp-1 and osteoporosis GLP 1

Caution notes If you have kidney disease or have been told to limit protein for medical reasons, check with your healthcare provider before increasing intake significantly

Funding This study was supported by the International Society of Hypertension (ISH) through the ISH grant for mentors (2017)

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the food and drug administration adverse event reporting system (FAERS)

I have been tracking data and decided to do a deep dive going back 5 yrs (Dec 2020 - Jan 2026) to see what I find

The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff